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Abstract
Retroviral resistance mediated by the murine Fv1 gene is believed to result from a direct interaction between the Fv1 gene product and
the viral capsid protein. To study the mechanism of Fv1 action, the expression and intracellular localisation of the Fv1 protein were
examined. Only very low levels of protein expression seem necessary for virus restriction but the site of expression appears crucial. Active
Fv1 was found in association with tubules of the trans-Golgi network, whereas an inactive form was localised in the endoplasmic reticulum.
We hypothesize that Fv1 is compartmentalised in the cell on the pathway taken by virus en route to the nucleus, suggesting that incoming
virus must pass the trans-Golgi network during its transit to the nucleus.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Friend virus susceptibility 1 (Fv1) was first described in
the 1970s as a gene in mice which conferred resistance to
infection with the murine leukemia virus (MLV) (Lilly,
1970). Mice that carried the Fv1n allele were susceptible to
N-tropic viruses but were resistant to B-tropic viruses (Lilly
and Pincus, 1973). Similarly, mice carrying the Fv1b allele
could be infected by B-tropic viruses but not by N-tropic
viruses. NB-tropic viruses are not restricted by either Fv1n
or Fv1b. As cell lines isolated from the mice retained their
ability to restrict viruses, it could be concluded that the
resistance to retroviral infection was an innate property of
the cells and was not conferred by the murine immune
response (Rosenberg and Jolicoeur, 1997). In vitro, Fv1
restriction was not absolute but reduced viral titres by 50 to
1000-fold (Hartley et al., 1970).
Fv1 has been cloned and sequenced. Intriguingly, it is
homologous to the gag sequence of an endogenous retrovi-
rus (Best et al., 1996). The Fv1b allele encodes a protein of
459 amino acids. Fv1n was found to be 19 amino acids
shorter than Fv1b. The two alleles also differ by two amino
acids near the C-terminus of the protein. Fv1b contains a
glutamic acid at position 358 and an arginine at position 399
while Fv1n contains lysine and valine at the respective
positions. Similar to the Gag protein of most retroviruses,
Fv1 contains a highly conserved sequence known as the
major homology region (MHR) (Be´nit et al., 1997). This
region has been shown to be essential for the viability of
retroviruses in both the early as well as the late stages of
their life cycle (Craven et al., 1995; Mammano et al., 1994;
Strambio-de-Castillia and Hunter, 1992). In Fv1, the integ-
rity of this region is required for function as the introduction
of nonconservative sequence changes abolishes its ability to
restrict (Bishop et al., 2001). Analysis of a number of Fv1
deletion mutants suggested the presence of two possible
functional domains in the protein, an N-terminal domain
and a C-terminal domain that are separated by a flexible
linker. This organisation was reminiscent of the structures
of the retroviral CA that have been solved (Clish et al.,
1998).
The mechanism by which Fv1 restricts MLV infection
remains unknown. Initial studies showed that Fv1 acts at an
early stage of the viral life cycle that is postentry but
preintegration (Jolicoeur, 1979; Pryciak and Varmus, 1992).
Furthermore, genetic evidence suggests that there might be
a direct interaction between Fv1 and CA of MLV (DesGro-
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seillers and Jolicoeur, 1983; Ou et al., 1983). A single
amino acid difference in position 110 in the MLV CA is
sufficient to alter the susceptibility of the virus to each allele
of Fv1 (Kozak and Chakraborti, 1996). In addition, CA has
been found to remain associated with the reverse transcrip-
tion and preintegration complexes that are present in the
early stages of the viral life cycle (Fassati and Goff, 1999).
To facilitate the study of Fv1, antibodies were raised in
rabbits (Bishop et al., 2001). They provide a valuable tool to
perform immunohistochemical analyses on the expression
of the protein. We hoped that such analyses could provide
more information about the manner in which Fv1 restricts
retroviruses. Further, it would be reasonable to assume that
Fv1 is associated with a compartment of the cell that the
incoming subviral particle navigates on its way to the nu-
cleus. Thus, knowledge of the site where Fv1 resides might
also provide some insight to the pathway of nuclear trans-
location by the preintegration complex, which still remains
unclear. With these aims in mind, we sought to determine
the cellular localisation of Fv1. This article describes the
results of these studies.
Results
Natural Fv1 expression levels are low
Our previous studies had suggested that natural levels of
Fv1 expression were likely to be low (Best et al., 1996;
Bock et al., 2000). Indeed, preliminary experiments using
conventional immunofluorescent methods failed to detect
Fv1 (results not shown). To assess the relative levels of
natural and transduced Fv1 expression, Western blot anal-
yses were performed on cell lysates from a variety of cells
(Fig. 1). Using 350 g of total protein from NIH3T3 and
BALB3T3 cells, a band of approximately 50 kDa, corre-
sponding to the predicted size of Fv1, could be detected
using an enhanced chemiluminescence detection system
(lanes 3 and 4). The band corresponding to Fv1n (lane 3)
was 10 times more intense than Fv1b (lane 4), suggesting
that Fv1n was expressed at a higher level than Fv1b, at least
in the cell lines examined. By contrast, a band of similar
size was detected with 40 g of total protein from cell
lysates of Mus dunni cells, a Fv1-null cell line (Lander and
Chattopadhyay, 1984), which had been transduced (m.o.i.
 1) with an MLV-based vector carrying Fv1n. This band
was severalfold more intense than that for NIH3T3 cells,
suggesting that Fv1n is expressed at significantly higher
levels from a MLV LTR than the natural promoter.
Correlation between localisation pattern of Fv1 and its
function
Given the difficulty of detecting the low natural levels of
Fv1 expression in NIH3T3 and BALB3T3 cells, we initially
focused on the localisation of Fv1 in cells that express the
gene at a higher level from a retroviral promoter. Immuno-
fluorescent staining was performed on M. dunni cells that
had been transduced with retroviral vectors carrying Fv1
(m.o.i. 1). A typical staining pattern for wild-type Fv1n is
shown in Fig. 2A. Fv1 seemed to be localised in punctate
structures that were clustered close to the nucleus of the cell.
These structures ranged from almost spherical to slightly
elongated and some were observed to contain a hollow
centre. No staining of the nucleus was observed. A few
spots were occasionally seen within the space of the nucleus
but these were always found to be in a focal plane that was
above the nucleus. The localisation pattern was identical
when the cells were fixed with either 4% paraformaldehyde
or methanol, showing that the observed distribution was not
an artefact of fixation. This pattern was quite similar to the
staining of vesicles or mitochondria in the cells (Allan,
2000). Transduced Fv1b showed an identical staining pat-
tern (results not shown).
Next, we examined the cellular localisation of a variety
of Fv1 mutants, constructed during our previous work on
the functional analysis of Fv1 (Bishop et al., 2001). All of
the mutants that retain the ability to restrict showed the
wild-type punctate staining pattern. These included neutral
MHR substitution mutants and an internal deletion mutant,
Int2-5, that was deleted from amino acid 123 to 202 (Bishop
et al., 2001) (see Fig. 3). The staining pattern of the mutants
that failed to restrict did not resemble wild type. Two
different patterns were observed for the nonrestricting mu-
tants. The first pattern was seen with Int1 (Fig. 3), which
was a mutant that was deleted from amino acids 109 to 118
in the proximal region of the protein when introduced at an
m.o.i.  1 (Bishop et al., 2001). It exhibited a staining
pattern that was very similar to that shown by the endoplas-
mic reticulum (data not shown) (Terasaki and Reese, 1992)
with a lacy patchwork of staining extending through the
cell. At higher multiplicity of transduction (m.o.i.  5),
aggregates of proteins could also be observed near the
nucleus in addition to the reticulate staining (Fig. 2B). The
signal from these aggregates was saturated in Fig. 2B as the
image had to be overexposed to reveal the reticulate pattern.
Fig. 1. Relative levels of Fv1 expression in transduced and nontransduced
cells. Western blot analysis of Fv1 expression in a variety of cell types.
Lane 1 was loaded with 40 g of protein, while lanes 2–4 were loaded with
350 g of total protein. The bands were detected by enhanced chemilu-
minescence after probing with an anti-Fv1 antibody used at 1:100 dilution
followed by HRP-conjugated protein A. As predicted from the relative
gene sizes, the product of the Fv1b allele shows reduced mobility compared
to Fv1n. Lane 1: Fv1n-transduced (m.o.i.  1) M. dunni cells. Lane 2:
Fv1-null M. dunni cells. Lane 3: NIH3T3 cells (naturally expressing Fv1n).
Lane 4: BALB3T3 cells (naturally expressing Fv1b).
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The second pattern of staining was seen with mutants that
were modified in the C-terminal third of Fv1 (Fig. 3). They
showed a staining pattern that appeared fibrous, with tubular
structures radiating from the nucleus (Fig. 2C). On longer
exposure, a fainter reticulate pattern could also be observed
underneath the fibres (Fig. 2D). The reticulate structure
could not be detected at lower exposure as it was much finer
and emitted a weaker fluorescence than the fibrous struc-
tures. This reticulate pattern was not observed when the
image of wild-type Fv1 was overexposed in a similar man-
ner. Mutants with this staining pattern include an internal
deletion mutant, Int10, which was deleted from amino acid
374 to 383, and the C-terminal deletion mutants, Fv1n (delta
411–440) and Fv1b (delta 411–459) (Bishop et al., 2001).
Fig. 2. Cellular distribution of wild-type Fv1 and its mutants. M. dunni cells were transduced with vectors encoding wild-type Fv1n (m.o.i.  1), Int1 (m.o.i.
 5), or Fv1n (delta 411–440) (m.o.i.  1). The cellular localisation of Fv1 was analysed 3 days posttransduction by immunofluorescence using an anti-Fv1
antibody followed by a TRITC-conjugated anti-rabbit antibody. (A) Fv1n showing punctate perinuclear distribution. (B) Int1, overexposed to reveal the
peripheral reticulate network. (C) Fv1n (delta 411–440) showing tubular distribution. (D) Fv1n(delta 411–440), overexposed to reveal the peripheral reticulate
network.
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The MHR-substitution mutants that failed to restrict also
showed this pattern of localisation. These observations sug-
gested that the localisation pattern of Fv1 was associated
with its ability to restrict. Difference in distribution patterns
between Int1 and C-terminal mutants also suggested that the
two types of mutants were disrupted in different ways.
Association between Fv1 and the cytoskeleton
Previous reports have documented a variety of interac-
tions between retroviral Gag proteins and the cytoskeleton.
These include the assembly and budding of the virus at the
cell surface during the late stages of the viral life cycle
(Damsky et al., 1977; Edbauer and Naso, 1983; Rey et al.,
1996), as well as the translocation of preintegration com-
plexes towards the nucleus during the early stages of infec-
tion (Chicurel, 2000). Since Fv1 is homologous to a retro-
viral Gag protein, we wondered if it was also associated
with the cytoskeleton. Double-labelled immunofluorescent
studies were carried out to determine if Fv1 colocalised with
the various components of the cytoskeleton.
The actin filaments were stained with tetramethylrho-
damine B isothiocyanate (TRITC)-conjugated phalloidin
(Wulf et al., 1979). There did not seem to be any colocal-
isation between the actin filaments and Fv1 (Fig. 4A). The
filaments were observed to run across the cell over the
nucleus, while Fv1 was found around the nucleus. The
microtubules were revealed using an antibody directed
against -tubulin (Gozes and Barnstable, 1982). There was
some degree of colocalisation between the punctate struc-
tures of Fv1 and the microtubule network (Fig. 4B). How-
ever, this only occurred near the nucleus and not along the
length of the microtubules, suggesting that Fv1 might be
associated with structures that are attached near the base of
the microtubules. The same observation was made when the
intermediate filaments were immunostained with antivimen-
tin (Fig. 4C). There appeared to be some degree of local-
isation between the intermediate filaments and Fv1 near the
nucleus of the cell.
To confirm the association of Fv1 with microtubules and
intermediate filaments, cytoskeleton-disrupting drugs were
used to treat Fv1-transduced cells and their effects on Fv1
localisation were observed. Cytochalasin D, which disrupts
actin filaments (Miranda et al., 1974), caused a general
collapse of the cell towards the nucleus (Fig. 5B). However,
the punctate, perinuclear distribution of Fv1 was unaffected,
confirming the lack of association between Fv1 and actin
filaments. Disrupting the cells with acrylamide, which
caused the collapse of the intermediate filament network
(Eckert, 1985), resulted in the accumulation of Fv1 to a
juxtanuclear position (Fig. 5C). The position of Fv1 corre-
sponded to the same side of the nucleus as the collapsed
intermediate filament network, although there was no abso-
lute colocalisation (results not shown). Treatment of the
cells with nocodazole, which depolymerises tubulin (De
Brabander et al., 1976), resulted in the most dramatic redis-
tribution of Fv1. The disruption of microtubules caused the
punctate structures of Fv1 to relocate throughout the cell
(Fig. 5D). While they were only perinuclear in untreated
cells, nocodazole treatment resulted in the punctate struc-
Fig. 3. Schematic representation of Fv1 mutants described in this study and their activities. The numbers indicate positions of amino acids in Fv1. Fv1b consists of
459 amino acids, while there are 440 amino acids in Fv1n. The stretches of sequence deleted are indicated as open boxes. Single amino acid changes are indicated
by the code of the amino acid in an open triangle. The activity of each mutant is indicated by “” for restriction and “” for no restriction.
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tures being found in the periphery of the cell as well. This
response to nocodazole treatment was characteristic of or-
ganelles that are attached to microtubules (Cole and Lip-
pincott-Schwartz, 1995), which include the various compo-
nents of the endocytic/exocytic pathway such as
endosomes, lysosomes, Golgi apparatus, and trans-Golgi
network (TGN). Hence, the data strongly suggested that Fv1
is localised in or on a cellular compartment that is associ-
ated with microtubules and intermediate filaments.
Association of Fv1 with the trans-Golgi network
In attempts to determine the site of localisation of Fv1 in
the cell, specific cellular components were stained with
fluorescent dyes in Fv1-transduced cells. Fv1 did not colo-
calise with mitochondria stained with MitoTracker red
(Poot et al., 1996) nor with lysosomes that were stained with
Lucifer yellow (Swanson et al., 1987) (results not shown).
Staining of the TGN with the dye BODIPY FL C5-ceramide
(Pagano et al., 1991) revealed a network of tubules that
radiated from the nucleus (Fig. 6B). In addition, a collection
of spherical perinuclear vesicles that stained more intensely
was also found close to the tubules. Fv1n did not colocalise
with any of the TGN vesicles that were stained by BODIPY
FL C5-ceramide. However, quite unexpectedly, the punctate
structures that contained Fv1n colocalised with some sec-
tions of the TGN tubules (Fig. 6A–C). A similar pattern of
colocalisation was also observed for Fv1b.
To confirm the localisation of Fv1, the position of Fv1 in
transduced cells was compared to that of TGN38, a trans-
membrane protein that was known to be resident in the TGN
(Luzio et al., 1990). TGN38 was present in a series of
perinuclear tubules (Fig. 6E). Consistent with the observa-
tions with BODIPY FL C5-ceramide, Fv1 was located along
sections of the tubules where TGN38 was found (Fig. 6D–
F). These results supported the notion that Fv1 was localised
to the tubules of the TGN in the transduced cells.
The TGN tubules in M. dunni cells resembled the radi-
ating fibrous structures seen in the localisation pattern of the
C-terminal mutants of Fv1 that did not restrict. This
prompted us to ask if the C-terminal mutants also localised
to the TGN tubules. Immunofluorescent staining was per-
formed on M. dunni cells that were transduced with the
various C-terminal mutants. These cells were also stained
with BODIPY TR-ceramide to reveal the TGN. A typical
staining pattern is shown by the MHR mutant, V282E
(Bishop et al., 2001) in Fig. 6G–I. As expected, the Fv1-
positive fibrous structures were found to colocalise with the
tubules of the TGN. The same pattern was seen with the
other nonrestricting MHR mutants, C-terminal truncation
mutants, as well as a mutant containing an internal deletion
near the C-terminus. Hence, the C-terminal mutants were
associated with the same cellular structures as the wild-type
protein. However, unlike the wild-type protein that was only
found associated with sections of the TGN tubules, the
C-terminal mutants were found along the whole length of
the tubules. One possible explanation could be that the
wild-type protein was capable of multimerising, thereby
forming aggregates at various sites on the tubules. The
C-terminal mutants, which were expressed at the same level
as the wild-type (Bishop et al., 2001), might have lost the
ability to multimerise/aggregate and therefore remain dis-
tributed along the length of the tubule.
In contrast, the N-terminal mutant Int1 (Bishop et al.,
2001), which showed a reticulate staining pattern, did not
colocalise with the TGN (Fig. 6J–L). This mutant was
deleted from amino acids 109 to 118. On close examination,
the tubules of the TGN were found to run through the gaps
in the Int1-positive reticulate structure. This structure colo-
calised with the endoplasmic reticulum, which was stained
green with AlexaFluor 488-conjugated concanavalin A
(Cottin et al., 1999) (Fig. 7). Hence, the N-terminal mutant
failed to localise in the same areas of the cell as the wild-
type protein and the C-terminal mutants. This suggested that
a signal required for proper localisation of Fv1 was present
in the region of the protein containing amino acids 109–
Fig. 4. Association of Fv1 with the cytoskeleton. Double-labelled immunofluorescence images stained to examine the association between Fv1 and the various
cytoskeletal components in Fv1-transduced (m.o.i.  1) M. dunni cells. (A) Actin filaments. Fv1n was stained green using an anti-Fv1 antibody followed by
a FITC-conjugated anti-rabbit antibody, while actin filaments were stained red with TRITC-conjugated phalloidin. (B) Microtubules. Fv1n was stained green
using an anti-Fv1 antibody followed by a FITC-conjugated anti-rabbit antibody, while microtubules were stained red with an anti--tubulin antibody followed
by a TRITC-conjugated anti-mouse antibody. (C) Intermediate filaments. Fv1n was stained red using an anti-Fv1 antibody followed by a TRITC-conjugated
anti-rabbit antibody, while vimentin filaments were stained green using an antivimentin antibody followed by a FITC-conjugated anti-goat antibody.
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118. Taken together, the localisation patterns of the wild-
type and mutant proteins were consisten with the notion of
a localisation domain in the N-terminal region of Fv1 and a
multimerisation/aggregation domain in the C-terminal third.
Localisation of endogenously expressed Fv1
The previous experiments had been performed using
Fv1-transduced M. dunni cells, where protein expression
was driven by the MLV LTR. This was more than 10-fold
higher than endogenous expression. We were therefore con-
cerned that the localisation observed with the transduced
protein could be an artefact of overexpression. Hence, it
seemed important to determine the localisation of endog-
enously expressed Fv1. As mentioned previously, it was
difficult to detect natural levels of Fv1 using conventional
immunostaining techniques. Hence, we sought to amplify
the signal using the tyramide signal amplification (TSA)
Fig. 5. Effect of cytoskeletal disruption on Fv1 distribution. Fv1n-transduced (m.o.i. 1) M. dunni cells were treated with agents that disrupt the cytoskeleton,
stained, and analysed by immunofluorescence. The cells were treated for 3 h at 37°C 3 days posttransduction before staining with an anti-Fv1 antibody
followed by a TRITC-conjugated anti-rabbit antibody. (A) No treatment. (B) Treatment with cytochalasin D at 1 g/ml which disrupts actin filaments. (C)
Treatment with 10 mM acrylamide which disrupts intermediate filaments. (D) Treatment with 66 M nocodazole which disrupts microtubules.
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system (Van Heusden et al., 1997) from Molecular Probes.
Briefly, a horseradish peroxidase (HRP) conjugated second-
ary antibody was added during the immunostaining proce-
dure. The HRP catalyses the activation of fluorescent tyra-
mide radicals, which are then covalently coupled to
nucleophilic residues that lie close to the HRP-target inter-
action site.
Using the TSA system, endogenously expressed Fv1n
appeared to be localised to perinuclear membranous struc-
tures in NIH3T3 cells (Fig. 8A, top cell). Although the
resolution was lower than conventional immunofluorescent
staining, these structures could be seen to be radiating from
the nucleus. Occasionally, some staining was observed in
the region of the nucleus but these were always found to be
in a focal plane that was above the nucleus. When the TGN
was revealed using BODIPY TR-ceramide (Ugur and Jones,
2000), the Fv1n-containing structures were seen to colo-
calise with TGN tubules (Fig. 8D). This was consistent with
the data from the studies with transduced cells. However,
unlike in the case of transduced cells where Fv1n was
localised in sections of the tubules, endogenously expressed
Fv1 seem to be found along the whole length of the tubules.
A possible explanation for this observation might be that the
levels of endogenously expressed Fv1n were too low to
result in aggregate formation.
M. dunni cells, which are Fv1-null, appeared to show a
low level of background signal with the TSA system. This
background could be due to nonspecific action of the pri-
mary antibody as no signal was detected with the HRP-
conjugated secondary antibody when the primary antibody
was omitted in the staining procedure (results not shown).
However, it was difficult to compare the difference in in-
tensity with the positive signal in NIH3T3 cells when the
two cell types were examined on separate coverslips. To
rule out the possibility that the localisation pattern in N3T3
cells was an artefact of background staining, GFP-trans-
duced M. dunni cells were seeded with NIH3T3 cells on the
same coverslip. The Fv1-negative cells emitted a green
fluorescence but had a low background staining with TSA
(bottom cell in Fig. 8A and C). In contrast, the NIH3T3
cells, which are Fv1n-positive, showed a more intense stain-
ing with TSA and did not emit any green fluorescence. This
confirmed that the Fv1 localisation pattern observed in
NIH3T3 cells was not an artefact of background staining.
Furthermore, while the TGN was stained with equal inten-
sity by BODIPY TR-ceramide in both NIH3T3 and GFP-M.
dunni cells (Fig. 8B), the tyramide signal was significantly
more intense in NIH3T3 cells (Fig. 8A). Hence, the local-
isation pattern was not due to the leaching of TGN signal
into the tyramide channel during image capture.
Attempts to visualise natural levels of Fv1b in BALB3T3
cells were unsuccessful even with signal amplification using
TSA. It was unlikely that this was due to poorer recognition
by the primary antibody as the anti-Fv1 antibody was a
polyclonal antibody generated by immunising with Fv1n,
which shared more than 94% homology with Fv1b. In light
Fig. 6. Colocalisation of Fv1 and the trans-Golgi network. Transduced (m.o.i.  1) M. dunni cells were fixed and stained 3 days posttransduction to reveal
the association between Fv1 and the trans-Golgi network. (A to C) Staining the TGN with BODIPY FL C5-ceramide. (A) Fv1n stained with an anti-Fv1
antibody followed by an Alexa Fluor 350-conjugated anti-rabbit antibody. (B) TGN stained with BODIPY FL C5-ceramide. (C) Merged images. (D to F)
Staining the TGN with anti-TGN38. (D) Fv1n stained with an anti-Fv1 antibody followed by a TRITC-conjugated anti-rabbit antibody. (E) TGN38 stained
with an anti-TGN38 antibody followed by a FITC-conjugated anti-mouse antibody. (F) Merged images. (G to I) Colocalisation of V282E MHR mutant and
the TGN marker BODIPY TR-ceramide. (G) V282E stained with an anti-Fv1 antibody followed by an Alexa Fluor 350-conjugated anti-rabbit antibody. (H)
TGN stained with BODIPY TR-ceramide. (I) Merged images. (J to L) Int1 and the TGN marker BODIPY FL C5-ceramide. (J) Int1 stained with an anti-Fv1
antibody followed by an Alexa Fluor 350-conjugated anti-rabbit antibody. (K) TGN stained with BODIPY FL C5-ceramide. (L) Merged images.
Fig. 7. Colocalisation of Int1 and the endoplasmic reticulum. Int1-transduced (m.o.i.  1) M. dunni cells were fixed and stained for Fv1 and the endoplasmic
reticulum marker Alexa Fluor 488-conjugated Concanavalin A. Fixing and staining were performed 3 days posttransduction. (A) Int1 stained with an anti-Fv1
antibody followed by an Alexa Fluor 350-conjugated anti-rabbit antibody. (B) Endoplasmic reticulum stained with Alexa Fluor 488-conjugated Concanavalin
A. (C) Merged images.
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of the results of the Western blot analyses performed on
endogenously expressed Fv1, it appears most likely that our
inability to detect Fv1b in BALB3T3 cells can be explained
by the significantly lower levels of protein expression.
Fv1 restriction appears independent of the mode of viral
entry
The TGN receives cargo from the endocytic pathway as
part of the route taken by some internalised receptors on
their return to the plasma membrane (Lemmon and Traub,
2000). As Fv1 was found to localise in the TGN, it was
tempting to speculate that following infection, MLV might
travel via the endocytic pathway to the TGN where it would
then encounter Fv1. Studies of Fv1 restriction had previ-
ously been performed with ecotropic viruses (Jolicoeur,
1979) or viruses pseudotyped with vesicular stomatitis virus
glycoprotein (VSV-G) (Bock et al., 2000). In both cases it
is believed that the newly infecting virus is internalised via
membrane fusion in endosomes (Katen et al., 2001; Kizhatil
and Albritton, 1997; Matlin et al., 1982). To investigate if
this route of entry is required for Fv1 restriction, restriction
assays were performed on viruses that are thought to enter
the cell by direct fusion at the plasma membrane. Two
different systems were used in this study. The first involved
using MLV particles pseudotyped with the 4070A ampho-
tropic envelope, which has been reported to be pH indepen-
dent for entry (McClure et al., 1990) and thus have been
presumed not to utilize an endosomal pathway (see Discus-
sion). The second system consisted of challenging Fv1-
transduced XC cells with ecotropic virions, which have
been described to enter via direct fusion at the surface of
these cells (Kizhatil and Albritton, 1997; McClure et al.,
1990).
The restriction assays were performed as described pre-
viously. The results are shown in Fig. 9. As we have pre-
viously shown (Bock et al., 2000), Fv1n-transduced M.
dunni cells were permissive for N- and NB-tropic viruses
pseudotyped with VSV-G but restricted VSV-G-
pseudotyped B-tropic viruses. In addition, Fv1b-transduced
M. dunni cells restricted VSV-G-pseudotyped N- and NB-
tropic viruses but not B-tropic viruses that were
pseudotyped with VSV-G. The ability to restrict did not
seem to depend on the viral envelope used as Fv1n-trans-
duced M. dunni cells were also able to restrict B-tropic
viruses pseudotyped with the 4070A envelope. Similarly,
Fv1b-transduced M. dunni cells were able to restrict N- and
NB-tropic viruses pseudotyped with the 4070A env gene.
Further, Fv1-transduced XC cells were also able to restrict
viruses containing the ecotropic envelope. Fv1n-transduced
Fig. 8. Colocalisation of endogenously expressed Fv1n and the TGN. NIH3T3 cells were mixed with EGFP-transduced (m.o.i. 5) M. dunni cells and plated
on coverslips. After 24 h cells were fixed and stained for Fv1 using an anti-Fv1 antibody followed by a HRP-conjugated anti-rabbit antibody. Pacific blue
labelled tyramide was then added to amplify the signal from Fv1. The TGN was stained using BODIPY TR-ceramide. A single pair of cells is shown: the
top cell is NIH3T3 and the bottom cell is M. dunni. (A) Fv1n; (B) TGN; (C) GFP; (D) merged.
Fig. 9. Restriction of viruses with different modes of cellular entry. The activity of each allele in M. dunni or XC cells against N-, B-, or NB-tropic tester
viruses pseudotyped with different envelopes is shown. M. dunni and XC cells were transduced (m.o.i.  1) with either Fv1n or Fv1b. The transduced cells
were challenged with tester viruses 2 days posttransduction. Tester viruses were produced by transfecting 293T cells with plasmids expressing a YFP-carrying
vector, N-, B-, or NB-tropic Gag/Gag-pol, and either VSV-G, 4070A, or ecotropic envelopes. Restriction was determined by analysing the proportion of
Fv1-containing cells that were transduced with the tester virus using FACS. The extent of restriction is described by symbols, as follows: , full restriction
(as shown by Fv1n restriction of B-tropic MLV and Fv1b restriction of N-tropic MLV); (), partial restriction; (), slight restriction; , no restriction.
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XC cells restricted B-tropic particles, while Fv1b-trans-
duced XC cells restricted N- and NB-tropic particles. These
data imply that Fv1 restriction is not dependent on the mode
of entry of viruses into the cytoplasm. Nevertheless, the fact
that restriction occurs suggests that the TGN might be a
compartment common to both surface and endosomal path-
ways of viral entry after membrane fusion had taken place.
Discussion
In this study, we have examined the expression of the
protein product of the mouse retrovirus restriction gene,
Fv1. We have shown (i) that natural levels of Fv1 expres-
sion are very low and (ii) the protein is localised primarily
in association with tubules of the TGN. We will now con-
sider these findings in the context of our present understand-
ing of the Fv1 gene and its mode of action.
The low levels of protein expression come as little sur-
prise in light of our previous experience with the Fv1 gene.
mRNA expression can only be detected by very sensitive
nuclease protection or PCR techniques (J.P. Stoye and P. Le
Tissier, unpublished data). This is consistent with the struc-
ture of the gene, where the inserted gag gene appears to be
transcribed from a normal cell promoter but in an antisense
direction relative to the promoter, and polyadenylation oc-
curs either via an inserted intracisternal A type particle LTR
(Fv1n allele) or at a B2 repeat (Fv1b allele) (Best et al.,
1996), (J.P. Stoye and P. Le Tissier, unpublished data).
Apparently consistent with the protein expression data, Fv1
mRNA is present at about threefold lower levels in
BALB3T3 cells than NIH3T3 cells (Ellis, 2000). The
greater amount of Fv1 found in NIH3T3 cells is also con-
sistent with earlier experiments on the hitness of infectivity,
which suggested that Fv1b restriction in BALB3T3 cells is
easier to overcome than Fv1n restriction in NIH3T3 cells
(Benjers et al., 1979).
The punctate pattern of localisation of overexpressed
Fv1 was similar to the localisation pattern observed with
several retroviral proteins. MoMLV--gal fusion proteins
were observed to localise to compartments that were remi-
niscent of rough ER-Golgi and numerous microvillus-type
structures, although the cellular compartments were not
verified by specific organelle markers (Jones et al., 1990).
HIV-1 Gag that was mutated in the N-terminal basic residue
cluster in the matrix domain localised near the Golgi and
TGN-proximal region (Hermida-Matsumoto and Resh,
2000). HTLV Gag did not seem to localise to any known
membranous cellular compartment, although it showed a
punctate cell localisation pattern (Le Blanc et al., 2002).
Having 60% identity to the Gag protein of HERV-L (Best et
al., 1996), it is perhaps not surprising that Fv1 is behaving
in a similar manner in cells. In addition, retroviral budding
into ER and Golgi has been detected (Hansen et al., 1993),
further supporting the association of Gag with intracellular
membranes. However, similar to other retroviral Gag pro-
teins, there is an absence of a classical signal peptide in the
N-terminus of Fv1. Hence, it is likely that the protein is
found on the cytosolic face of the membranes of the TGN
and ER. This would be consistent with the annular struc-
tures seen in our initial analyses.
There seemed to be a correlation between restriction and
the association of Fv1 with the TGN, as the mutant, Int1,
which failed to restrict, did not localise to the TGN, al-
though it was found in the ER. The presence of Int1 in the
ER also suggested that the localisation signal might com-
prise two components: one which brought the protein to the
ER, while the other allowed it to move to the TGN. The
mutant, Int1, might be impaired in the second signal com-
ponent, resulting in its retention in the ER. Colocalisation of
Fv1 with the TGN was necessary but not sufficient for its
activity, as there were nonrestricting mutants which were
found in the TGN. Unlike wild-type Fv1, these mutants,
which were modified in the C-terminal third, were found
along the length of the TGN tubules, suggesting that they
might lack the ability to multimerise. Although the distri-
bution of these mutants resembled that of endogenous Fv1n,
the failure to form punctate structures that were seen in the
wild-type was not due to lower concentrations of the mutant
proteins. This was because both wild-type and mutants were
expressed from identical retroviral promoters in the trans-
duced cells and had been found to be expressed at similar
levels previously (Bishop et al., 2001). Current co-immu-
noprecipitation experiments strongly suggest the presence
of a multimerisation domain in the C-terminal region of
Fv1. Co-immunoprecipitation was not seen with the MHR
mutants that failed to restrict (M.W. Yap and J.P. Stoye,
unpublished data) and we speculate that Fv1 activity may
require multimerisation. Int1 was a mutant that seemed to
retain its multimerisation function, although it was unable to
localise to the TGN. Hence, it could probably interact with
wild-type Fv1. It will be interesting to see if Int1 could
abrogate wild-type Fv1 function by preventing it from lo-
calising to the correct cellular compartment.
The association of Fv1 with the TGN suggested that
incoming viruses passed through this cellular compartment
where interaction with Fv1 occurred. The TGN is an or-
ganelle involved in the later stages of sorting in the exocy-
totic pathway (Traub and Kornfeld, 1997). It also receives
cargo from the endocytotic pathway (Lemmon and Traub,
2000). In particular, some internalised receptors pass
through this cellular component following receptor-medi-
ated endocytosis before they are recycled back to the plasma
membrane (Straley and Green, 2000; Vandenbulcke et al.,
2000; Yamashiro et al., 1984). Hence, it is conceivable that
viruses internalised by endocytosis after binding to their
receptors could be transported to the TGN as part of the
route taken to the nucleus. Entry into the cytoplasm could
take place from this cellular compartment. Alternatively,
fusion between the viral and host membrane might take
place in the endosomes, after which the virus could remain
associated with the endocytic pathway. We found that Fv1
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restriction also affected viruses that were previously de-
scribed to enter at the cell surface, suggesting that these
viruses might also pass through the TGN during the infec-
tion process. However, recent evidence from studies of
avian retrovirus entry indicated that pH independence might
not provide a reliable means for discriminating between
sites of virus–cell membrane fusion (Mothes et al., 2000).
Hence, we cannot exclude the possibility that MLVs con-
taining Env which are pH-independent for membrane fusion
could still enter the cell via the endocytic pathway. An
alternative explanation for the restriction of these viruses
could be that the actual interaction between Fv1 and the
incoming virus might occur elsewhere, although the major-
ity of Fv1 was localized to the TGN. To address this issue,
we are currently attempting to label the virus with a fluoro-
phore to follow its pathway in the cell.
Previous studies have not revealed any difference in
integration activity measured in vitro using preintegration
complexes isolated from Fv1-restricted or nonrestricted
cells (Pryciak and Varmus, 1992). The absence of Fv1 from
the nucleus provides further evidence that restriction of
viruses occurs prior to integration. Localisation of Fv1 in a
cytosolic compartment suggests that restriction takes place
before entry of the preintegration complex into the nucleus.
Normal levels of nucleus-associated linear DNA have been
reported in Fv1-restricted cells, but reduced DNA circles
were seen (Pryciak and Varmus, 1992). It is thus tempting
to speculate that a late step in nuclear translocation might be
affected. Attempts at labelling the preintegration complex
could provide some insight to this possibility.
In conclusion, Fv1 seemed to behave similar to a con-
ventional retroviral protein in terms of its localisation and
multimerisation. It might represent a truncated Gag that is
impaired in its ability to assemble into viral particles but
retains the features allowing it to form multimers that asso-
ciate with the TGN. The multimeric form of Fv1 might
interact with incoming MLV in this cellular compartment.
Work is currently ongoing to study the nature of the inter-
action between Fv1 and MLV CA.
Materials and methods
Recombinant DNA
Fv1 and its mutants were introduced into M. dunni cells
by transduction with MLV-based vectors. The plasmids
encoding these vectors that were constructed previously
also contained an IRES and egfp for restriction analysis
(Bishop et al., 2001). The green fluorescence of GFP was
not desirable for some of the immunofluorescence studies. It
was removed from the vectors by deleting the SalI-NotI
fragment, filling the recessed ends with Klenow enzyme
followed by re-ligation of the vector.
Source of antibodies and chemicals
The rabbit anti-Fv1 antibody had been described previ-
ously (Bishop et al., 2001). Monoclonal antitubulin, FITC-
conjugated anti-rabbit IgG, FITC, and TRITC-conjugated
anti-mouse IgG were purchased from Sigma. Goat antivi-
mentin, rhodamine-conjugated anti-rabbit, and FITC-conju-
gated anti-goat IgG were purchased from Santa Cruz Lab-
oratories. Monoclonal anti-TGN38 was purchased from BD
Transduction Laboratories. HRP-conjugated protein A was
purchased from Bio-Rad. BODIPY FL C5 ceramide,
BODIPY TR ceramide, Alexa Fluor 488-conjugated Con-
canavalin A, Lucifer yellow, MitoTracker red, Alexa Fluor
350-conjugated anti-rabbit IgG, and the Pacific blue la-
belled Tyramide system amplification kit were purchased
from Molecular Probes.
Cells and viruses
All cell lines were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum
and antibiotics. Viruses were produced using the transient
three-plasmid expression system as described previously
(Bock et al., 2000; Soneoka et al., 1995). Briefly, plasmids
providing env, gag/gag-pol, and vector, respectively, were
introduced into 293T cells using the calcium phosphate
transfection method. Seventeen hours posttransfection the
cells were treated with 10 mM sodium butyrate in DMEM
for 8 h. The virus-containing supernatant was harvested 12 h
after sodium butyrate treatment and passed through a
0.45-m filter before storage at 70°C.
Restriction assay
Restriction assays were performed as previously de-
scribed (Bock et al., 2000). Briefly, cells were seeded in
12-well plates at a density of 2  104 cells per well. The
cells were then transduced with retroviral vectors carrying
Fv1 and egfp. Two days posttransduction, the transduced
cells were split 1 in 15 into 12-well plates and challenged
with tester viruses carrying the yfp marker and containing
either N-, B-, or NB-tropic capsids. FACS analysis was
performed on the cells 2 days posttransduction to determine
the percentage of cells expressing Fv1 that were transduced
by the tester virus.
Western blot analysis
Fv1n-transduced M. dunni cells were seeded into 6-cm
dishes, while NIH3T3, BALB3T3, and M. dunni cells were
seeded into 13-cm dishes and grown to confluencey. The
cell monolayer was washed once with PBS and the cells
were lysed with triple-detergent lysis buffer [50 mM
Tris–Cl (pH 8.0) 150 mM NaCl, 0.02% sodium azide, 0.1%
SDS, 1% Nonidet P-40, and 0.5% sodium deoxycholate]
containing complete miniprotease inhibitor cocktail (Roche)
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for 20 min at 4°C. Cells in the 6-cm dishes were lysed with
0.5 ml triple-detergent lysis buffer, while 1 ml lysis buffer
was used for cells in 13-cm dishes. The lysate was cleared
by centrifugation in a microfuge at 4°C for 10 min. The
protein concentration of each lysate was determined by
performing a Bradford assay (Bio-Rad). Typically, 350 g
protein was loaded into each well of a 10% polyacrylamide
gel for NIH3T3, BALB3T3, and M dunni cells, while 40 g
protein was loaded for Fv1n-transduced M. dunni cells. The
proteins were boiled in SDS loading buffer containing 10
mM dithiothreitol and separated by polyacrylamide gel
electrophoresis before transferring onto an Immobilon P
membrane (Millipore) using a semidry transfer apparatus
(Ancos). The membrane was blocked overnight at 4°C with
5% milk in PBS containing 1% Tween 20 (PBS-T). The
anti-Fv1 antibody was diluted 1 in 100 in PBS-T containing
5% milk and added to the membrane for 1 h at room
temperature. The membrane was washed four times with
PBS-T containing 0.5% milk for 5 min each. HRP-conju-
gated protein A, diluted 1 in 1000 in PBS-T containing 5%
milk, was then added to the membrane. Four more washes
were performed on the membrane for 5 min each. Finally,
the protein bands were detected using the enhanced chemi-
luminescence (ECL) system from Amersham. Quantitation
of the intensity of the bands was performed using the Image
Station 440CF from Kodak Digital Science.
Immunofluorescence labelling and microscopy
M. dunni cells were seeded at a density of 2  104 cells
in 12-well plates. The cells were transduced with retroviral
vectors carrying Fv1 or its various mutants the next day.
Two days posttransduction, the cells were split 1 in 15 onto
13-mm coverslips in 12-well plates. The following day, the
cells were washed once with PBS and fixed with 4% para-
formaldehyde in PBS for 15 min at room temperature. They
were then permeabilized with 0.2% Triton X in PBS for 15
min at room temperature except for detection of TGN38,
when the cells were permeabilized with ice-cold methanol
at 20°C for 15 min. The permeabilized cells were washed
once with PBS and blocked for 20 min at room temperature
with PBS containing 1% BSA. Primary antibodies were
then added to the cells at the appropriate dilutions in PBS
containing 1% BSA. Rabbit anti-Fv1 and monoclonal anti-
tubulin were used at dilutions of 1:200, while goat antivi-
mentin and monoclonal anti-TGN38 were used at dilutions
of 1:100 and 1:50, respectively. The cells were incubated
with the primary antibody for 1 h at room temperature
before washing three times with PBS containing 1% BSA.
Secondary antibodies and organelle-specific fluorescent
dyes were then added at the appropriate dilutions in PBS
containing 1% BSA. Rhodamine-conjugated anti-rabbit IgG
and FITC-conjugated anti-goat IgG were used at dilutions
of 1:400, while TRITC-conjugated anti-mouse IgG and
FITC-conjugated anti-rabbit IgG were used at dilutions of
1:200. FITC-conjugated anti-mouse IgG was used at dilu-
tions of 1:128, while AlexaFluor 350-conjugated anti-rabbit
IgG was used at dilutions of 1:100. TRITC-conjugated
phalloidin and AlexaFluor 488-conjugated Concanavalin A
were used at concentrations of 0.66 M and 5 g/ml,
respectively, while BODIPY FL C5-ceramide and BODIPY
TR-ceramide were used at 5 M. The cells were incubated
with the secondary antibodies and fluorescent dyes for 40
min before washing three times with PBS for 5 min each.
Finally, the coverslips were mounted in Citifluor (Agar
Scientific) and sealed with nail varnish.
For detection of endogenously expressed Fv1 using the
TSA system from Molecular Probes, cells were seeded onto
13-mm coverslips in 12-well plates at densities of 2 104 cells
per well. The cells were fixed and permeabilized as described
above. They were then blocked using PBS containing 1% of
blocking reagent for 1 h at room temperature. Anti-Fv1 was
added at a dilution of 1:1000 in PBS containing 1% blocking
reagent and incubated at room temperature for 1 h. The cells
were washed three times in PBS for 5 min each. HRP-conju-
gated anti-rabbit IgG (Molecular Probes) was then added at a
dilution of 1:100 in PBS containing 1% blocking reagent and
incubated at room temperature for another hour. Three washes
in PBS of 5 min each were performed at room temperature.
Pacific blue-labelled tyramide reagent was then diluted 1:100
in amplification buffer containing 0.0015% hydrogen peroxide
and added to the cells for 5 min at room temperature. The cells
were washed three times in PBS for 5 min each at room
temperature. The coverslips were then mounted in Citifluor
(Agar Scientific) and sealed with nail varnish.
All microscopy was performed on an Olympus IX in-
verted microscope with phase contrast and DIC optics using
a Photometrics CH350L liquid-cooled CCD camera with a
Kodak KAF1400 sensor. A 100 oil immersion objective
lens was used to examine the specimens.
Disruption of cytoskeleton
M. dunni cells were transduced with Fv1 and seeded onto
13-mm coverslips as described above. Prior to fixation, the
medium containing the transduced cells was replaced with
prewarmed medium containing the appropriate concentrations
of cytoskeleton-disrupting chemicals. Cytochalasin D (Sigma),
which disrupted the actin filaments, was used at a concentra-
tion of 1 g/ml. Nocodazole (Sigma), which depolymerized
microtubules, was used at 66 M. Acrylamide (BDH), which
caused the collapse of intermediate filaments, was used at 10
mM. The cells were treated with the cytoskeleton-disrupting
drugs for 3 h at 37°C before fixing and processing for immu-
nofluorescence labelling as described above.
Acknowledgments
We thank Michael Bock, Kate Bishop, and Sebastien
Nisole for helpful discussions. This work was supported by
the United Kingdom Medical Research Council.
87M.W. Yap, J.P. Stoye / Virology 307 (2003) 76–89
References
Allan, V.J., 2000. Basic immunofluorescence microscopy, in: Allan, V.J.
(Ed.), Protein localization by fluorescence microscopy—A practical
approach, Oxford Univ. Press, Oxford, pp. 1–26.
Be´nit, L., de Parseval, N., Casella, J.-F., Callebaut, I., Cordonnier, A.,
Heidmann, T., 1997. Cloning of a new murine endogenous retrovirus,
MuERV-L, with strong similarity to the human HERV-L element and
a gag coding sequence closely related to the Fv1 restriction gene.
J. Virol. 71, 5652–5657.
Benjers, B.M., Bassin, R.H., Rein, A., Gerwin, B.I., Duran-Troise, G.,
1979. Mechanism of restriction of murine leukemia viruses varies
between different strains of Fv-1n mice. Int. J. Cancer 24, 600–607.
Best, S., Le Tissier, P., Towers, G., Stoye, J.P., 1996. Positional cloning of
the mouse retrovirus restriction gene Fv1. Nature 382, 826–829.
Bishop, K.N., Bock, M., Towers, G., Stoye, J.P., 2001. Identification of the
regions of Fv1 necessary for MLV restriction. J. Virol 75 (11), 5182–
5188.
Bock, M., Bishop, K.N., Towers, G., Stoye, J.P., 2002. Use of a transient
assay for studying the genetic determinants of Fv1 restriction. J. Virol.
74, 7422–7430.
Chicurel, M., 2000. Virology. Probing HIV’s elusive activities within the
host cell. Science 290 (5498), 1876–1879.
Clish, C.B., Peyton, D.H., Barklis, E., 1998. Solution structures of human
immunodeficiency virus type 1 (HIV-1) and moloney murine leukemia
virus (MoMLV) capsid protein major-homology-region peptide ana-
logs by NMR spectroscopy. Eur. J. Biochem. 257 (1), 69–77.
Cole, N.B., Lippincott-Schwartz, J., 1995. Organization of organelles and
membrane traffic by microtubules. Curr. Opin. Cell Biol. 7 (1), 55–64.
Cottin, V., Van Linden, A., Riches, D.W., 1999. Phosphorylation of tumor
necrosis factor receptor CD120a (p55) by p42(mapk/erk2) induces
changes in its subcellular localization. J. Biol. Chem. 274 (46), 32975–
32987.
Craven, R.C., Leure-duPree, A.E., Weldon, R.A. Jr., and Wills, J.W., 1995.
Genetic analysis of the major homology region of the Rous sarcoma
virus Gag protein. J. Virol. 69, 4213–4227.
Damsky, C.H., Sheffield, J.B., Tuszynski, G.P., Warren, L., 1977. Is there
a role for actin in virus budding? J. Cell. Biol. 75 (2 Pt. 1), 593–605.
De Brabander, M.J., Van de Veire, R.M., Aerts, F.E., Borgers, M., Janssen,
P.A., 1976. The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimi-
dazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic anti-
tumoral drug interfering with microtubules, on mammalian cells cul-
tured in vitro. Cancer Res. 36 (3), 905–916.
DesGroseillers, L., Jolicoeur, P., 1983. Physical mapping of the Fv-1
tropism host range determinant of BALB/c murine leukemia viruses.
J. Virol. 48 (3), 685–696.
Eckert, B.S., 1985. Alteration of intermediate filament distribution in PtK1
cells by acrylamide. Eur. J. Cell Biol. 37, 169–174.
Edbauer, C.A., Naso, R.B., 1983. Cytoskeleton-associated Pr65gag and
retrovirus assembly. Virology 130 (2), 415–426.
Ellis, S., 2000. Ph.D. Thesis, Univ. of London, London.
Fassati, A., Goff, S.P., 1999. Characterization of intracellular reverse
transcription complexes of moloney murine leukemia virus. J. Virol. 73
(11), 8919–8925.
Gozes, I., Barnstable, C.J., 1982. Monoclonal antibodies that recognize
discrete forms of tubulin. Proc. Natl. Acad. Sci. USA 79 (8), 2579–
2583.
Hansen, M., Jelinek, L., Jones, R.S., Stegeman-Olsen, J., Barklis, E., 1993.
Assembly and composition of intracellular particles formed by Molo-
ney murine leukemia virus. J. Virol. 67 (9), 5163–5174.
Hartley, J.W., Rowe, W.P., Huebner, R.J., 1970. Host-range restrictions of
murine leukemia viruses in mouse embryo cell cultures. J. Virol. 5,
221–225.
Hermida-Matsumoto, L., Resh, M.D., 2000. Localization of human immu-
nodeficiency virus type 1 Gag and Env at the plasma membrane by
confocal imaging. J. Virol. 74 (18), 8670–8679.
Jolicoeur, P., 1979. The Fv-1 gene of the mouse and its control of murine
leukemia virus replication. Curr. Top. Microbiol. Immunol. 86, 67–
122.
Jones, T.A., Blaug, G., Hansen, M., Barklis, E., 1990. Assembly of gag-
beta-galactosidase proteins into retrovirus particles. J. Virol. 64 (5),
2265–2279.
Katen, L.J., Januszeski, M.M., Anderson, W.F., Hasenkrug, K.J., Evans,
L.H., 2001. Infectious entry by amphotropic as well as ecotropic
murine leukemia viruses occurs through an endocytic pathway. J. Virol.
75 (11), 501–5026.
Kizhatil, K., Albritton, L.M., 1997. Requirements for different components
of the host cell cytoskeleton distinguish ecotropic murine leukemia
virus entry via endocytosis from entry via surface fusion. J. Virol. 71
(10), 7145–7156.
Kozak, C.A., Chakraborti, A., 1996. Single amino acid changes in the
murine leukemia virus capsid protein gene define the target for Fv1
resistance. Virology 225, 300–306.
Lander, M.R., Chattopadhyay, S.K., 1984. A Mus dunni cell line that lacks
sequences closely related to endogenous murine leukemia viruses and
can be infected by ecotropic, amphotropic, xenotropic and mink cell
focus-forming viruses. J. Virol. 52 (2), 695–698.
Le Blanc, I., Blot, V., Bouchaert, I., Salamero, J., Goud, B., Rosenberg,
A.R., Dokhelar, M.C., 2002. Intracellular distribution of human T-cell
leukemia virus type 1 Gag proteins is independent of interaction with
intracellular membranes. J. Virol. 76 (2), 905–911.
Lemmon, S.K., Traub, L.M., 2000. Sorting in the endosomal system in
yeast and animal cells. Curr. Opin. Cell Biol. 12 (4), 457–466.
Lilly, F., 1970. Fv-2: identification and location of a second gene govern-
ing the spleen focus response to Friend leukemia virus in mice. J. Natl.
Cancer Inst. 45, 163–169.
Lilly, F., Pincus, T., 1973. Genetic control of murine viral leukemogenesis.
Adv. Cancer Res. 17, 231–277.
Luzio, J.P., Brake, B., Banting, G., Howell, K.E., Braghetta, P., Stanley,
K.K., 1990. Identification, sequencing and expression of an integral
membrane protein of the trans-Golgi network (TGN38). Biochem. J.
270 (1), 97–102.
Mammano, F., O¨ hagen, A., Ho¨glund, S., Go¨ttlinger, H.G., 1994. Role of
the major homology region of human immunodeficiency virus type 1 in
virion morphogenesis. J. Virol. 68, 4927–4936.
Matlin, K.S., Reggio, H., Helenius, A., Simons, K., 1982. Pathway of
vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156
(3), 609–631.
McClure, M.O., Sommerfelt, M.A., Marsh, M., Weiss, R.A., 1990. The pH
independence of mammalian retrovirus infection. J. Gen. Virol. 71 (Pt.
4), 767–773.
Miranda, A.F., Godman, G.C., Tanenbaum, S.W., 1974. Action of cytocha-
lasin D on cells of established lines. II. Cortex and microfilaments.
J. Cell. Biol. 62 (2), 406–423.
Mothes, W., Boerger, A.L., Narayan, S., Cunningham, J.M., Young, J.A.,
2000. Retroviral entry mediated by receptor priming and low pH
triggering of an envelope glycoprotein. Cell 103 (4), 679–689.
Ou, C.-Y., Boone, L.R., Koh, C.-K., Tennant, R.W., Yang, W.K., 1993.
Nucleotide sequences of the gag-pol regions that determine the Fv-1
host range property of BALB/c N-tropic and B-tropic murine leukemia
viruses. J. Virol. 48 (3), 779–784.
Pagano, R.E., Martin, O.C., Kang, H.C., Haugland, R.P., 1991. A novel
fluorescent ceramide analogue for studying membrane traffic in animal
cells: accumulation at the Golgi apparatus results in altered spectral
properties of the sphingolipid precursor. J. Cell. Biol. 113 (6), 1267–
1279.
Poot, M., Zhang, Y.Z., Kramer, J.A., Wells, K.S., Jones, L.J., Hanzel,
D.K., Lugade, A.G., Singer, V.L., Haugland, R.P., 1996. Analysis of
mitochondrial morphology and function with novel fixable fluorescent
stains. J. Histochem. Cytochem. 44 (12), 1363–1372.
Pryciak, P.M., Varmus, H.E., 1992. Fv-1 restriction and its effects on
murine leukemia virus integration in vivo and in vitro. J. Virol. 66,
5959–5966.
88 M.W. Yap, J.P. Stoye / Virology 307 (2003) 76–89
Rey, O., Canon, J., Krogstad, P., 1996. HIV-1 Gag protein associates with
F-actin present in microfilaments. Virology 220 (2), 530–534.
Rosenberg, N., Jolicoeur, P., 1997. Retroviral pathogenesis. Chapter
10. in: Coffin, J.M., Hughes, S.H., Varmus, H.E. (Eds.), Retrovi-
ruses, Cold Spring Harbor Press, Cold Spring Harbor, NY, pp.
475–585.
Soneoka, Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Romano, G.,
Kingsman, S.M., Kingsman, A.J., 1995. A transient three-plasmid
expression system for the production of high titer retroviral vectors.
Nucl. Acids Res. 23, 628–633.
Straley, K.S., Green, S.A., 2000. Rapid transport of internalized P-Selec-
tion to late endosomes and the TGN: roles in regulating cell surface
expression and recycling to secretory granules. J. Cell. Biol. 151,
107–116.
Strambio-de-Castillia, C., Hunter, E., 1992. Mutational analysis of the
major homology region of Mason-Pfizer monkey virus by use of
saturation mutagenesis. J. Virol. 66 (12), 7021–7032.
Swanson, J., Bushnell, A., Silverstein, S.C., 1987. Tubular lysosome mor-
phology and distribution within macrophages depend on the integrity of
cytoplasmic microtubules. Proc. Natl. Acad. Sci. USA 84 (7), 1921–
1925.
Terasaki, M., Reese, T.S., 1992. Characterization of endoplasmic reticulum
by co-localization of BiP and dicarbocyanine dyes. J. Cell. Sci. 101 (Pt.
2), 315–322.
Traub, L.M., Kornfeld, S., 1997. The trans-Golgi network: a late secretory
sorting station. Curr. Opin. Cell. Biol. 9 (4), 527–533.
Ugur, O., Jones, T.L., 2000. A proline-rich region and nearby cysteine
residues target XLalphas to the Golgi complex region. Mol. Biol. Cell.
11 (4), 1421–1432.
Van Heusden, J., de Jong, P., Ramaekers, F., Bruwiere, H., Borgers, M.,
Smets, G., 1997. Fluorescein-labeled tyramide strongly enhances the
detection of low bromodeoxyuridine incorporation levels. J. Histo-
chem. Cytochem. 45 (2), 315–319.
Vandenbulcke, F., Nouel, D., Vincent, J.P., Mazella, J., Beaudet, A., 200.
Ligand-induced internalization of neurotensin in transfected COS-7
cells: differential intracellular trafficking of ligand and receptor. J. Cell
Sci. 113, 2963–2975.
Wulf, E., Deboben, A., Bautz, F.A., Faulstich, H., Wieland, T., 1997.
Fluorescent phallotoxin, a tool for the visualization of cellular actin.
Proc. Natl. Acad. Sci. USA 76 (9), 4498–4502.
Yamashiro, D.J., Tycko, B., Fluss, S.R., Maxfield, F.R., 1984. Segregation
of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the
recycling pathway. Cell 37, 789–800.
89M.W. Yap, J.P. Stoye / Virology 307 (2003) 76–89
